Thus, the TF-specific IgM and IgA antibody levels were decreased in gastric cancer patients irrespective of the stage of cancer with some dependency on tumor morphology, while the anti-TFIgG level was slightly decreased in patients with advanced cancer only. The gene discussed is CD79A; the disease is neoplasm.